India is witnessing a rapid surge in the number of COVID-19 cases with new instances being reported everyday. Recognizing the severity of the coronavirus pandemic, the Indian government announced a three-week nationwide lockdown until April 14, 2020. While India has taken lessons from other countries’ experiences and has ramped up measures to practice social distancing, it has one of the world’s lowest testing rates for coronavirus. As the number of cases in India continue to rise, what can be done to scale up the testing efforts, isolate suspected individuals, trace their contacts, and prevent community transmission?
Carnegie India hosted a virtual discussion with Taslimarif Saiyed and Shahid Jameel as they examined India’s response to the coronavirus outbreak, technology solutions for medical countermeasures, regulations that can help fast track the development and commercialization of such interventions, and the role scientists as well as industry can play to enhance India’s response capacity. The discussion was moderated by Rudra Chaudhuri.
Shahid Jameel is the chief executive officer of the Wellcome Trust/DBT India Alliance.
Taslimarif Saiyed is the chief executive officer and director of the Centre for Cellular and Molecular Platforms (C-CAMP).
Rudra Chaudhuri is the director of Carnegie India.